Below are the most recent publications written about "Bacterial Vaccines" by people in Profiles.
-
Elko EA, Williamson CHD, Green HR, Gates-Hollingsworth MA, Nelson GA, Pandit SG, Mead HL, Allender C, Woerle C, Mayo M, Currie BJ, AuCoin DP, Altin JA, Keim P, Settles EW, Ladner JT. PepSeq as a highly multiplexed platform for melioidosis antigen discovery and vaccine development. Front Immunol. 2025; 16:1605758.
-
Richardson S, Medhavi FNU, Tanner T, Lundy S, Omosun Y, Igietseme JU, Eko FO. Role of route of delivery on Chlamydia abortus vaccine-induced immune responses and genital tract immunity in mice. Microbes Infect. 2025 Mar-Apr; 27(3):105463.
-
Tanner T, Medhavi FNU, Richardson S, Omosun YO, Eko FO. In silico design and analysis of a multiepitope vaccine against Chlamydia. Pathog Dis. 2024 02 07; 82.
-
Richardson S, Bell CR, Medhavi F, Tanner T, Lundy S, Omosun Y, Igietseme JU, Eko FO. A novel cold-chain free VCG-based subunit vaccine protects against Chlamydia abortus-induced neonatal mortality in a pregnant mouse model. Front Immunol. 2023; 14:1243743.
-
Richardson S, Medhavi F, Tanner T, Lundy S, Omosun Y, Igietseme JU, Carroll D, Eko FO. Cellular Basis for the Enhanced Efficacy of the Fms-Like Tyrosine Kinase 3 Ligand (FL) Adjuvanted VCG-Based Chlamydia abortus Vaccine. Front Immunol. 2021; 12:698737.
-
Zuo Z, Zou Y, Li Q, Guo Y, Zhang T, Wu J, He C, Eko FO. Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge. Sci Rep. 2021 05 17; 11(1):10389.
-
Howard S, Richardson S, Benyeogor I, Omosun Y, Dye K, Medhavi F, Lundy S, Adebayo O, Igietseme JU, Eko FO. Differential miRNA Profiles Correlate With Disparate Immunity Outcomes Associated With Vaccine Immunization and Chlamydial Infection. Front Immunol. 2021; 12:625318.
-
Gries CM, Mohan RR, Morikis D, Lo DD. Crosslinked flagella as a stabilized vaccine adjuvant scaffold. BMC Biotechnol. 2019 07 18; 19(1):48.
-
Pais R, Omosun Y, Igietseme JU, Fujihashi K, Eko FO. Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses. Front Immunol. 2019; 10:1577.
-
Lin YH, Chen Y, Smith TC, Karna SLR, Seshu J. Short-Chain Fatty Acids Alter Metabolic and Virulence Attributes of Borrelia burgdorferi. Infect Immun. 2018 09; 86(9).